Our findings align with the hypothesis that alterations in selenoprotein levels could potentially be involved in the pathophysiology of depression and anxiety through previously researched mechanisms related to oxidative stress and inflammation [45]. The gene discussed is SELENOS; the disease is depressive symptom measurement.